Better Health for All

Jinxin Technology Holding Company's core business in assisted reproductive technologies (ART), prenatal care, and gynecological health delivers exceptional health benefits, with Sichuan Jinxin Xinan Hospital surpassing 100,000 total pregnancy cases.

The company reports no products with significant negative health impacts. It maintains an outstanding safety record, with Shenzhen Zhongshan Hospital reporting a 97.33% average patient satisfaction rate and a 0.20% complaint rate. The company demonstrates excellent risk transparency, with 84% of employees receiving anti-corruption training and zero reports of ethical misconduct in 2024. Healthcare data responsibility is strong, with an Information Security Management System in place and zero major security risk incidents reported. The company provides substantial healthcare education, conducting 144 prenatal lectures and 48 obstetric mini-classes. It offers substantial support for the healthcare workforce, with 135 hands-on training sessions for 2,300 attendees. Efforts to improve price accessibility include RMB 3 million in medication subsidies and over 1,000 free consultations. The company also works to improve vulnerable reach by covering over 20,000 people through free clinic activities and cooperating with grassroots healthcare institutions in ethnic minority areas. Mental health initiatives include assessments, free community clinics, and public health education sessions.

Fair Trade & Ethical Sourcing

The provided SEC filing for Jinxin Technology Holding Company contains no data relevant to fair trade, ethical sourcing, or the company's supply chain practices.

Therefore, no metrics from the requested list can be extracted or scored.

Honest & Fair Business

Jinxin Technology Holding Company changed its independent registered public accounting firm from WWC, P.C. to Summit Group CPAs, P.C., effective July 11, 2025.

WWC issued clean audit opinions for fiscal years 2022-2024, with no qualifications or adverse language. No disagreements or reportable events occurred between the company and WWC during FY 2023-2024 and up to July 11, 2025. However, the company has unresolved material weaknesses in internal control over financial reporting, specifically a shortage of personnel knowledgeable in U.S. GAAP and SEC requirements.

No War, No Weapons

The provided articles contain no specific, quantitative data or information relevant to NAMI.US's involvement in arms manufacturing, military contracts, dual-use technologies, sales to sanctioned regimes, peacebuilding investments, or any other metrics related to the 'No War, No Weapons' ethical value.

explicitly states no relevant quantitative data is present, and provides no information about NAMI.US or any company's involvement in conflict-related activities.

Planet-Friendly Business

The provided articles do not contain specific, quantitative data points that can be mapped to the defined KPIs for Planet-Friendly Business. While one article mentions an environmental investment of approximately USD 1,100,000 in 2024 and the purchase of 100,000 kWh of green electricity in the same year, these are absolute figures and cannot be assessed against KPIs requiring percentages of total consumption or EBIT, which are not provided.

The statement of a "100% legal waste disposal rate" does not provide a waste diversion rate. Information regarding carbon emissions, science-based targets, water use, green building certifications, or supply chain climate transparency is explicitly stated as absent or not available across the articles.

Safe & Smart Tech

The company adheres to U.S. regulatory standards (SEC).

It operates under numerous regulatory requirements in China, including the Cybersecurity Law, Data Security Law, and Personal Information Protection Law. It has received immaterial fines for failing to obtain certain licenses in China.

Zero Waste & Sustainable Products

The company reported a near 100% waste diversion rate for general solid waste in 2022, with 164,554.03 tons of recyclable waste out of 164,554.11 tons of total general solid waste.

The company has implemented over 10 waste reduction initiatives, including using non-toxic raw materials, promoting green office practices, double-sided printing, smart canteen services to reduce food waste, and reducing mercury-containing medical supplies. It has set ambitious waste reduction targets for 2025, aiming for a 40% reduction in hazardous waste, a 34% reduction in energy consumption, a 20% reduction in water consumption, and a 34% reduction in greenhouse gas emissions per million yuan of operating revenue, all compared to a 2020 baseline. By 2023, the company had achieved a 33.90% reduction in hazardous waste emissions, a 26.21% reduction in water consumption, and a 14.02% reduction in greenhouse gas emissions per RMB million of revenue compared to 2020. The company's environmental management system is ISO 14000 certified, and it has a Hazardous Waste Management System in place, collaborating with professional third parties for disposal. The company conducts annual waste audits for all major facilities and evaluates suppliers regularly, including environmental factors, prioritizing those committed to energy efficiency and emissions reduction. However, in 2022, Jiuzhou Hospital received one environmental administrative penalty for violating regulations on polluted water discharge.